Samuel Backenroth, Chief Financial Officer at Ohr Pharmaceutical Inc (OHRP), bought 142,858 shares at $0.70 ($100K) on 2017-04-10, disclosed to the SEC on 2017-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.70 | 71,429 | $50K | 50.0% |
| 2 | $0.70 | 71,429 | $50K | 50.0% |
| Total | $0.70 avg | 142,858 | $100K | 100% |
| Filing → |
| OHRP | BUY | 2016-05-24 | $8K | — | Filing → |
| OHRP | BUY | 2015-02-10 | $10K | — | Filing → |